Muscle-bone crosstalk and potential therapies for sarco-osteoporosis
Muscle-bone crosstalk and potential therapies for sarco-osteoporosis
复制标题
DOI:
10.1002/jcb.28946
复制
发表时间:
2019-09-01
影响因子:
4
通讯作者:
Shang, Peng
中科院分区:
文献类型:
--
作者:
Li, GuoBin;Zhang, Lan;Shang, Peng
The nature of muscle-bone crosstalk has been historically considered to be only mechanical, where the muscle is the load applier while bone provides the attachment sites. However, this dogma has been challenged with the emerging notion that bone and muscle act as secretory endocrine organs affect the function of each other. Biochemical crosstalk occurs through myokines such as myostatin, irisin, interleukin (IL)-6, IL-7, IL-15, insulin-like growth factor-1, fibroblast growth factor (FGF)-2, and beta-aminoisobutyric acid and through bone-derived factors including FGF23, prostaglandin E-2, transforming growth factor beta, osteocalcin, and sclerostin. Aside from the biochemical and mechanical interaction, additional factors including aging, circadian rhythm, nervous system network, nutrition intake, and exosomes also have effects on bone-muscle crosstalk. Here, we summarize the current research progress in the area, which may be conductive to identify potential novel therapies for the osteoporosis and sarcopenia, especially when they develop in parallel.